Moon Sung Ho, Shin Kyung Hwan, Kim Tae Hyun, Yoon Myonggeun, Park Soah, Lee Doo-Hyun, Kim Jong Won, Kim Dae Woong, Park Sung Yong, Cho Kwan Ho
Proton Therapy Center, National Cancer Center, Gyeonggi-do, Republic of Korea.
Radiother Oncol. 2009 Jan;90(1):66-73. doi: 10.1016/j.radonc.2008.09.027. Epub 2008 Nov 5.
As an alternative to whole breast irradiation in early breast cancer, a variety of accelerated partial breast irradiation (APBI) techniques have been investigated. The purpose of our study is to compare the dosimetry of four different external beam APBI (EB-APBI) plans: three-dimensional conformal radiation therapy (3D-CRT), intensity-modulated radiation therapy (IMRT), helical tomotherapy (TOMO), and proton beam therapy (PBT).
Thirty patients were included in the study, and plans for four techniques were developed for each patient. A total dose of 30Gy in 6Gy fractions once daily was prescribed in all treatment plans.
In the analysis of the non-PTV breast volume that was delivered 50% of the prescribed dose (PD), PBT (mean: 16.5%) was superior to TOMO (mean: 22.8%), IMRT (mean: 33.3%), and 3D-CRT (mean: 40.9%) (p<0.001). The average ipsilateral lung volume percentage receiving 20% of the PD was significantly lower in PBT (0.4%) and IMRT (2.3%) compared with 3D-CRT (6.0%) and TOMO (14.2%) (p<0.001). The average heart volume percentage receiving 20% and 10% of the PD in left-sided breast cancer (N=19) was significantly larger with TOMO (8.0%, 19.4%) compared to 3D-CRT (1.5%, 3.1%), IMRT (1.2%, 4.0%), and PBT (0%, 0%) (p<0.001).
All four EB-APBI techniques showed acceptable coverage of the PTV. However, effective non-PTV breast sparing was achieved at the cost of considerable dose exposure to the lung and heart in TOMO.
作为早期乳腺癌全乳照射的替代方法,人们对多种加速部分乳腺照射(APBI)技术进行了研究。我们研究的目的是比较四种不同的外照射APBI(EB-APBI)计划的剂量学:三维适形放射治疗(3D-CRT)、调强放射治疗(IMRT)、螺旋断层放疗(TOMO)和质子束治疗(PBT)。
30例患者纳入本研究,为每位患者制定了四种技术的计划。所有治疗计划均规定总剂量为30Gy,分6Gy,每日一次。
在对接受50%处方剂量(PD)的非计划靶区(PTV)乳腺体积的分析中,PBT(平均值:16.5%)优于TOMO(平均值:22.8%)、IMRT(平均值:33.3%)和3D-CRT(平均值:40.9%)(p<0.001)。与3D-CRT(6.0%)和TOMO(14.2%)相比,接受2百分之0 PD的平均同侧肺体积百分比在PBT(0.4%)和IMRT(2.3%)中显著更低(p<0.001)。在左侧乳腺癌(N=19)中,接受20%和10% PD的平均心脏体积百分比在TOMO(8.0%,19.)中显著大于3D-CRT(1.5%,3.1%)、IMRT(1.2%,4.0%)和PBT(0%,0%)(p<0.001)。
所有四种EB-APBI技术对PTV均显示出可接受的覆盖范围。然而,TOMO在有效 sparing非PTV乳腺的同时,代价是肺和心脏受到相当大的剂量照射。